tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

JNJJohnson & Johnson

Health care · Pharmaceuticals · NYSE
Compare with peers → Embed

The biggest changes in the 10-K filed 2026-02-11, this fiscal year against the last, and the sentences in the MD&A (Item 7) where management explains them, quoted word for word. Tickdelta picks sentences that name the line, a direction and a cause. It does not write explanations of its own.

Net income

+90.6% Big change FY to 2025-12-28 vs 2024-12-29

The MD&A has no sentence that names a cause for this change. That can be worth a question: ask about the filing.

Gross margin

69.1% → 67.9% (-1.2 pts) Big change FY to 2025-12-28 vs 2024-12-29

The MD&A has no sentence that names a cause for this change. That can be worth a question: ask about the filing.

Revenue

+6.0% FY to 2025-12-28 vs 2024-12-29

“Sales increase/(decrease) due to: 2025 2024”

Read it in the 10-K ↗

“The net impact of acquisitions and divestitures on the worldwide sales growth was a positive impact of 1.1% in 2025, primarily related to CAPLYTA and Shockwave and a positive impact of 0.5% in 2024 primarily related to Shockwave.”

Read it in the 10-K ↗

Cash from operations

+1.1% FY to 2025-12-28 vs 2024-12-29

The MD&A has no sentence that names a cause for this change. That can be worth a question: ask about the filing.

Changes are computed from the XBRL figures in the same 10-K. Hover a number to see the line item. Open the 10-K ↗

Next Accounting checks →

Work on JNJ in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/JNJ/export.csv") into a cell.